1. Home
  2. LAW vs NBTX Comparison

LAW vs NBTX Comparison

Compare LAW & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LAW
  • NBTX
  • Stock Information
  • Founded
  • LAW 2013
  • NBTX 2003
  • Country
  • LAW United States
  • NBTX France
  • Employees
  • LAW N/A
  • NBTX N/A
  • Industry
  • LAW Computer Software: Prepackaged Software
  • NBTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LAW Technology
  • NBTX Health Care
  • Exchange
  • LAW Nasdaq
  • NBTX Nasdaq
  • Market Cap
  • LAW 249.3M
  • NBTX 211.9M
  • IPO Year
  • LAW 2021
  • NBTX 2020
  • Fundamental
  • Price
  • LAW $6.26
  • NBTX $10.20
  • Analyst Decision
  • LAW Buy
  • NBTX Strong Buy
  • Analyst Count
  • LAW 2
  • NBTX 1
  • Target Price
  • LAW $6.75
  • NBTX $8.00
  • AVG Volume (30 Days)
  • LAW 116.1K
  • NBTX 14.0K
  • Earning Date
  • LAW 11-05-2025
  • NBTX 09-18-2025
  • Dividend Yield
  • LAW N/A
  • NBTX N/A
  • EPS Growth
  • LAW N/A
  • NBTX N/A
  • EPS
  • LAW N/A
  • NBTX N/A
  • Revenue
  • LAW $148,024,000.00
  • NBTX N/A
  • Revenue This Year
  • LAW $7.13
  • NBTX N/A
  • Revenue Next Year
  • LAW $6.25
  • NBTX $74.67
  • P/E Ratio
  • LAW N/A
  • NBTX N/A
  • Revenue Growth
  • LAW 4.05
  • NBTX N/A
  • 52 Week Low
  • LAW $3.31
  • NBTX $2.76
  • 52 Week High
  • LAW $6.64
  • NBTX $10.96
  • Technical
  • Relative Strength Index (RSI)
  • LAW 79.04
  • NBTX 65.13
  • Support Level
  • LAW $5.51
  • NBTX $9.32
  • Resistance Level
  • LAW $5.78
  • NBTX $10.46
  • Average True Range (ATR)
  • LAW 0.21
  • NBTX 0.59
  • MACD
  • LAW 0.04
  • NBTX 0.01
  • Stochastic Oscillator
  • LAW 82.09
  • NBTX 74.15

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: